摘要:
A method for inhibiting for inhibiting the ability of a biomaterial to sorb antimicrobials comprising binding a cationic polysaccharide to the surface of said biomaterial.
摘要:
Method for inhibiting adhesion of bacteria to the surface of a biomedical device comprising binding a cationic polysaccharide to the surface of said biomedical device.
摘要:
A method for wetting a contact lens comprising administering an aqueous wetting solution comprising 0.001 to 10.0 percent by weight of a cationic cellulosic polymer provided that the solution has an ionic strength of less than about 0.10.
摘要:
A composition for treating, reducing, ameliorating, or alleviating a back-of-the- eye condition or disorder that has an etiology in inflammation comprises a dissociated glucocorticoid receptor agonist ('DIGRA'). The compositions also can include other anti-inflamatory agents, anti-angiogenic agents, or combinations thereof. The composition can be formulated for topical application, injection, or implantation. The composition can be administered alone or in combination with another procedure chosen to enhance the outcome of the treatment.
摘要:
A composition for treating, controlling, reducing, ameliorating, or preventing allergy comprises a dissociated glucocorticoid receptor agonist ('DIGRA'), a prodrug thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable ester thereof. The composition can comprise an anti-allergic medicament and/or an additional anti-inflammatory agent and can be formulated for topical application, injection, or implantation. The anti-allergic medicament can comprise an antihistamine, a mast-cell stabilizer, a leukotriene inhibitor, an immunomodulator, an anti-IgE agent, or a combination thereof.
摘要:
A composition for treating, controlling, reducing, ameliorating, or preventing allergy comprises a dissociated glucocorticoid receptor agonist ('DIGRA'), a prodrug thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable ester thereof. The composition can comprise an anti-allergic medicament and/or an additional anti-inflammatory agent and can be formulated for topical application, injection, or implantation. The anti-allergic medicament can comprise an antihistamine, a mast-cell stabilizer, a leukotriene inhibitor, an immunomodulator, an anti-IgE agent, or a combination thereof.
摘要:
A composition for treating, reducing, ameliorating, or alleviating a back-of-the- eye condition or disorder that has an etiology in inflammation comprises a dissociated glucocorticoid receptor agonist ('DIGRA'). The compositions also can include other anti-inflamatory agents, anti-angiogenic agents, or combinations thereof. The composition can be formulated for topical application, injection, or implantation. The composition can be administered alone or in combination with another procedure chosen to enhance the outcome of the treatment.
摘要:
The use of a composition of one or more cationic polysaccharides in combination with one or more antimicrobial agents to disinfect contact lenses and preserve ophthalmic lens compositions is described. Ophthalmic lens solutions containing compositions of one or more cationic polysaccharides in combination with one or more antimicrobial agents and methods of making and using the same are also described.
摘要:
Compositions for inhibiting attachment of microorganisms to the surface of biomaterials include a polyether, such as a poloxamer. The compositions are especially useful for treating contact lenses to prevent bacterial attachment to the lens.
摘要:
Ophthalmic compositions such as eye drop and contact lens treating solutions include a polycationic material to enhance antimicrobial efficacy against protozoans such as acanthamoebae. One preferred class of polycationic materials is cationic cellulose derivatives.